Ryan D Cassaday

Ryan D Cassaday

UNVERIFIED PROFILE

Are you Ryan D Cassaday?   Register this Author

Register author
Ryan D Cassaday

Ryan D Cassaday

Publications by authors named "Ryan D Cassaday"

Are you Ryan D Cassaday?   Register this Author

38Publications

888Reads

22Profile Views

When a randomized controlled trial is unlikely: Propensity score analysis of blinatumomab in adults with relapsed/refractory Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.

Authors:
Ryan D Cassaday

Cancer 2019 Oct 18. Epub 2019 Oct 18.

Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32565DOI Listing
October 2019

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.

Clin Cancer Res 2019 Sep 3. Epub 2019 Sep 3.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1567DOI Listing
September 2019

Long-Term Follow-Up of Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma.

Biol Blood Marrow Transplant 2018 11 3;24(11):2211-2215. Epub 2018 Jul 3.

Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183038
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.06.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251312PMC
November 2018

Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.

Am J Hematol 2018 08 27;93(4):546-552. Epub 2018 Jan 27.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25030DOI Listing
August 2018

Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma.

Biol Blood Marrow Transplant 2018 02 20;24(2):282-287. Epub 2017 Oct 20.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173079
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.10.029DOI Listing
February 2018

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm.

Am J Hematol 2017 May 20;92(5):E75-E77. Epub 2017 Mar 20.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24696
Publisher Site
http://dx.doi.org/10.1002/ajh.24696DOI Listing
May 2017

Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy.

Clin Lymphoma Myeloma Leuk 2017 04 10;17(4):225-230. Epub 2017 Jan 10.

Seattle Cancer Care Alliance, Seattle, WA; Department of Medicine, University of Washington School of Medicine, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650163064
Publisher Site
http://dx.doi.org/10.1016/j.clml.2016.12.004DOI Listing
April 2017

Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review.

Case Rep Hematol 2017 21;2017:2676254. Epub 2017 Feb 21.

Department of Medicine, University of Washington School of Medicine, P.O. Box 356420, 1959 NE Pacific Street, Seattle, WA 98195, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/2676254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339518PMC
February 2017

What is the role of transplantation for indolent lymphoma?

Am Soc Clin Oncol Educ Book 2012 :494-500

From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.494DOI Listing
April 2016

A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphoma.

Clin Lymphoma Myeloma Leuk 2015 Jul 5;15(7):392-7. Epub 2015 Mar 5.

Department of Medicine, University of Washington School of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650150006
Publisher Site
http://dx.doi.org/10.1016/j.clml.2015.02.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484300PMC
July 2015

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biol Blood Marrow Transplant 2015 Feb 1;21(2):281-7. Epub 2014 Nov 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408880PMC
February 2015

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.

Nucl Med Commun 2014 Nov;35(11):1132-42

Departments of aRadiology bMedicine, Division of Medical Oncology, University of Washington Medical Center cClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington dDepartment of Radiology, Harvard Medical School, MGH Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169733PMC
November 2014

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.

Biol Blood Marrow Transplant 2014 Jun 12;20(6):770-5. Epub 2014 Feb 12.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019701PMC
June 2014

Allogeneic hematopoietic cell transplantation in mantle cell lymphoma.

Best Pract Res Clin Haematol 2012 Jun 3;25(2):165-74. Epub 2012 May 3.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2012.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374153PMC
June 2012

Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature.

Clin Lymphoma Myeloma Leuk 2011 Jun 20;11(3):289-92. Epub 2011 Apr 20.

Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI 53705-2275, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.018DOI Listing
June 2011

Cell-specific transgene expression from a widely transcribed promoter using Cre/lox in mice.

Genesis 2002 Apr;32(4):277-86

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53226, USA.

View Article

Download full-text PDF

Source
April 2002